Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for treatment of hereditary cystatin C amyloid angiopathy (HCCAA) and other neurodegenerative disorder associated with aberrant amyloid deposits

Compositions and methods for treatment of hereditary cystatin C amyloid angiopathy (HCCAA) and other neurodegenerative disorder associated with aberrant amyloid deposits

US Patent 11338009 · Granted May 24, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for the diagnosis and treatment of lymphatic system dis2025
Compositions and methods for the diagnosis and treatment of lymphatic system dis2025
Compositions and methods for the diagnosis and treatment of lymphatic system dis2025
Colored titanium dioxide asphalt compositions2025
Association of genetic variations to diagnose and treat attention-deficit hypera2024
Nonselective metabotropic glutamate receptor activators for treatment of attenti2024
Compositions and methods targeting the Th2 pathway for the treatment of asthma2024
Methods of diagnosing and treating conduct disorder2023
Methods of diagnosing and treating anxiety disorder2023
Nonselective metabotropic glutamate receptor activators for treatment of anorexi2023
Methods for use in the diagnosis of autoimmune diseases2023
Methods of diagnosing and treating ADHD in biomarker positive subjects2023